Literature DB >> 9627353

Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.

E Hindié1, D Mellière, C Jeanguillaume, L Perlemuter, F Chéhadé, P Galle.   

Abstract

UNLABELLED: Technetium-99m-sestamibi represents an important advance in the scintigraphic location of parathyroid neoplasms. However, the optimal procedure for 99mTc-sestamibi parathyroid scanning has not been defined. The first objective of this work was to optimize the technical aspects of subtraction scanning, using simultaneous double-window recording of 99mTc-sestamibi and 1231 instead of successive image recording. The second objective was to compare two protocols for detecting abnormal parathyroid glands: subtraction scanning and single-tracer double-phase scanning.
METHODS: Thirty patients referred for first surgery of primary hyperparathyroidism had both subtraction scanning and double-phase scanning in the same imaging session. Images of 99mTc-sestamibi and 123I were recorded simultaneously in nonoverlapping windows and then subtracted. For double-phase scanning, images of 99mTc-sestamibi, acquired 15 min and 120 min after tracer injection, were visually compared. Surgery disclosed a solitary adenoma in 27 patients, bilateral adenomata in 2 patients and 3 hyperplastic glands in the last patient. No patient had persistent hypercalcemia.
RESULTS: Preoperative 99mTc-sestamibi/123I subtraction scanning located 25 of 27 solitary adenomas, the bilateral adenomata and 3 of 3 hyperplastic glands. The overall sensitivity for enlarged parathyroids was 94%, and the false-positive image rate was 3%. The 99mTc-sestamibi single-tracer technique located 22 of 27 solitary adenomas, the bilateral adenomata and 1 of 3 hyperplastic glands. Overall sensitivity was 79% and the false-positive image rate was 10%. The gamma camera imaging time was 30 min for the subtraction technique and 50 min for the single-tracer double-phase study. An ectopic adenoma in the sheath of the right carotid artery was detected by both techniques.
CONCLUSION: These results, together with other data in the literature, indicate that 99mTc-sestamibi/123I subtraction imaging is accurate in locating enlarged parathyroids. Classical difficulties of this technique (motion artifacts and prolonged immobilization) were avoided by using simultaneous recording of the two isotopes. In this series subtraction imaging was more rapid and more sensitive (p < 0.04) than the single-tracer technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627353

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

1.  The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.

Authors:  N Glynn; N Lynn; C Donagh; R K Crowley; D Smith; C J Thompson; A D K Hill; F Keeling; A Agha
Journal:  Ir J Med Sci       Date:  2010-11-13       Impact factor: 1.568

2.  The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy.

Authors:  J G Norman; C E Jaffray; H Chheda
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery.

Authors:  Domenico Rubello; Arianna Massaro; Silvia Cittadin; Lucia Rampin; Adil Al-Nahhas; Giuseppe Boni; Giuliano Mariani; Maria Rosa Pelizzo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-28       Impact factor: 9.236

4.  18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Authors:  Alessio Imperiale; David Taïeb; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04       Impact factor: 9.236

5.  Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas.

Authors:  Y S Kushchayeva; S H Tella; S V Kushchayev; D Van Nostrand; K Kulkarni
Journal:  Osteoporos Int       Date:  2019-01-31       Impact factor: 4.507

6.  Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism.

Authors:  Elif Hindié; Paolo Zanotti-Fregonara; Pierre-Alexandre Just; Emile Sarfati; Didier Mellière; Marie-Elisabeth Toubert; Jean-Luc Moretti; Christian Jeanguillaume; Isabelle Keller; Pablo Ureña-Torres
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-28       Impact factor: 9.236

7.  [Primary hyperparathyroidism: parathyroid scintigraphy and ultrasound in problem patients].

Authors:  E Van De Flierdt; A Dropmann; J Böck; F Spelsberg; H Fürst
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

8.  Value of 123I-subtraction and single-photon emission computed tomography in addition to planar 99mTc-MIBI scintigraphy before parathyroid surgery.

Authors:  Francisca H Jorna; Pieter L Jager; Tjin H Que; Clara Lemstra; John T M Plukker
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

Review 9.  Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature.

Authors:  Martin Gotthardt; Bodo Lohmann; Thomas M Behr; Artur Bauhofer; Christiane Franzius; Meike L Schipper; Maria Wagner; Helmut Höffken; Helmut Sitter; Matthias Rothmund; Klaus Joseph; Christoph Nies
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

Review 10.  Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT.

Authors:  David Taïeb; Pablo Ureña-Torres; Paolo Zanotti-Fregonara; Domenico Rubello; Alice Ferretti; Ioline Henter; Jean-François Henry; Francesca Schiavi; Giuseppe Opocher; Johan G Blickman; Patrick M Colletti; Elif Hindié
Journal:  Clin Nucl Med       Date:  2013-08       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.